Ovarian C4161001
Study #C4161001Phase 1/2A Dose Escalation, Finding and Expansion Study Evaluation Safety Tolerability, Pharmacokinetics, Pharmacodynamics and Anti Tumor Activity of PF-07104091 as a Single Agent and in Combination Therapy
Back To Clinical Trials NCI Database Entry